Stay updated on Linvoseltamab Combo Therapy in Resistant Myeloma Clinical Trial

Sign up to get notified when there's something new on the Linvoseltamab Combo Therapy in Resistant Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Linvoseltamab Combo Therapy in Resistant Myeloma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-05-01T03:38:43.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The webpage has been updated to include new drugs for the treatment of Multiple Myeloma, such as Lenalidomide, Bortezomib, Pomalidomide, Isatuximab, Fianlimab, Cemiplimab, and Nirogacestat, while removing detailed information about a previous study involving linvoseltamab.
    Difference
    37%
    Check dated 2025-04-16T14:23:01.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for March 7, 2025, while a date for March 25, 2025, has been removed.
    Difference
    0.2%
    Check dated 2025-04-09T09:12:25.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version (v2.14.3) and a new last update date of March 25, 2025, replacing the previous version (v2.14.2) and date of March 7, 2025.
    Difference
    0.1%
    Check dated 2025-04-01T23:10:36.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The webpage has updated its location listings, adding new entries for hospitals in Paris and Lille while removing previous listings for the same locations. Additionally, the dates have been updated to reflect more recent information.
    Difference
    2%
    Check dated 2025-03-11T04:29:18.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The page has updated key location and institutional names, including a change from 'University of Texas Southwestern Medical Center' to 'University of Texas Southwestern' and from 'CHU de Montpellier' to 'CHU Montpellier - Departement D'Hematologie'. Additionally, there are new dates listed.
    Difference
    1%
    Check dated 2025-02-24T20:45:33.000Z thumbnail image

Stay in the know with updates to Linvoseltamab Combo Therapy in Resistant Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Linvoseltamab Combo Therapy in Resistant Myeloma Clinical Trial page.